Methods of purifying recombinant ADAMTS13 and other proteins and compositions thereof
AssigneeTakeda Pharmaceutical Company Limited
InventorsMeinhard Hasslacher, Christian Fiedler, Artur Mitterer
Life of this patent
Estimating the term…
Loading patent…
AssigneeTakeda Pharmaceutical Company Limited
InventorsMeinhard Hasslacher, Christian Fiedler, Artur Mitterer
Estimating the term…
Provided herein are methods for purifying recombinant A Disintegrin-like and Metallopeptidase with Thrombospondin Type 1 Motif 13 (ADAMTS13) protein from a sample. The method comprises enriching for ADAMTS13 protein by chromatographically contacting the sample with hydroxyapatite under conditions that allow ADAMTS13 protein to appear in the eluate or supernatant from the hydroxylapatite. The methods may further comprise tandem chromatography with a mixed mode cation exchange/hydrophobic interaction resin that binds ADAMTS13 protein. Additional optional steps involve ultrafiltration/diafiltration, anion exchange chromatography, cation exchange chromatography, and viral inactivation. Also provided herein are methods for inactivating virus contaminants in protein samples, where the protein is immobilized on a support. Also provided herein are compositions of ADAMTS13 prepared according to said methods.
An in vitro method for purifying a therapeutic protein composition, said method comprising:
An in vitro method for purifying a composition comprising ADAMTS13, said method comprising:
An in vitro method for inactivating a lipid-enveloped virus contaminant in a protein solution during the purification of a therapeutic protein composition, said method comprising:
Dependencies are inferred from the claim text.